Navigation Links
Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
Date:1/12/2010

conomic Development Zone in Laiyang City, Shandong Province. Jiangbo produces both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. For additional information, please visit the Company's website (http://www.jiangbopharma.com ).

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from anticipated or predicted results, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's ability to obtain raw materials needed in manufacturing, the continuing employment of key employees, the failure risks inherent in testing any new drug, the possibility that regulatory approvals may be delayed or become unavailable, patent or licensing concerns that may include litigation, direct competition from other manufacturers and product obsolescence. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

    For further information, please contact:

    Jiangbo Pharmaceuticals, Inc.
 
'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
2. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Decision Resources Group finds that the markets for peripheral ... Russia , India ... see robust expansion as these economies expand and as ... revenues will be somewhat impeded by poor distribution of ... and demand for low-cost products, the market will ultimately ...
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds that the ... Australia , China , India ... at a strong rate through 2023. Dental implant procedure volumes will ... patient awareness rises. Other key findings from Decision Resources ... implant market: , Dental implant penetration: Penetration of ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
Breaking Medicine Technology:Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
... Council on Exercise (ACE), America,s leading authority on fitness ... organization in the world, today announced the launch of ... in America.  As an extension of the organization,s vision ... engage in physical activity and inspire them to make ...
... Hologic, Inc. (Hologic or the Company) (Nasdaq: ... premium diagnostics products, medical imaging systems and surgical products dedicated ... products that are the future of women,s imaging at the ... McCormick Place in Chicago, November 28 through December 2, 2010. ...
Cached Medicine Technology:American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 2American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 3Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 2Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 3Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 4Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 5Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 6Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 7Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 8Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010 9
(Date:9/30/2014)... 2014 The American Diabetes Association ... diabetics curb their sweet tooth, but the most recent ... September, suggests that zero-calorie sweeteners may actually be linked ... , The Weizmann Institute of Science in Israel ... to mice, the mice developed glucose intolerance. They then ...
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set ... Nashville, Tennessee. RMS welcomes the launch of an entirely ... of a new treatment center for the Lung Institute. ... Institute to Nashville, the hope is to bring awareness ... diagnosed and undiagnosed. With Nashville being a hub for ...
(Date:9/30/2014)... Sept. 30, 2014 (HealthDay News) -- Medicare should cover ... high risk for the disease, a coalition of more ... coalition, which includes the Lung Cancer Alliance, the Society ... American Cancer Society and the American Society of Clinical ... to the U.S. Centers for Medicare & Medicaid Services ...
(Date:9/30/2014)... Healthcare advocates, patient navigators, healthcare providers and caregivers ... Consultants (#NAHAC) fifth annual conference, “Mastering the Power and ... 30th - Nov. 1st, 2014 in Chicago, Illinois. ... Practices for the Field of Healthcare Advocacy. As ... a set of standards and best practices. NAHAC stepped ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 To mark ... Editorial Board of Living with a Disability magazine ... light on hematological disorders as disabling conditions. ... more than a diagnosis to establish a disability related ... thrombocytomenia, myelofibrosis, hereditary telangiectasia, coagulation defects, polycythemia vera, and ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Regenerative Medicine Solutions Expanding 2Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3
... NAPA, Calif., Feb. 6 Senetek PLC (OTC,Bulletin ... the development,of technologies that target the science of ... new website; http://www.senetekplc.com ., Mr. Frank ... are pleased to bring greater visibility to Senetek ...
... to come, WASHINGTON, Feb. 6 Across five ... people and supplies,are flowing in to provide care to ... 5. In every tornado-affected,community, Red Cross workers are on ... rescue workers, and lending emotional support to,all., More ...
... are both highly effective in treating mild to moderately severe ... Medicine have found the first study to compare the ... skin disorder. , Peels using beta-hydroxy acid (or BHA) had ... longer than did peels using alpha-hydroxy acid (or AHA), the ...
... clinical trial involving the use of gene therapy in combination ... more effective than radiation therapy alone for patients with intermediate ... a $9 million grant from the National Cancer Institute (NCI) ... therapy to treat prostate cancer. , As part ...
... seek restatement of Beth Israel Deaconess,Medical Center audit, ... T. Linde should apply the same Sarbanes-Oxley,standards used by ... on the board of Beth Israel Deaconess Medical Center ... East. Linde is,also the president and CFO of Boston ...
... saving treatment option for people with end-stage liver disease. ... supply. Each year only about one-third of people who ... patients die while waiting. In the February issue of ... for allocating donor organs in the United States affects ...
Cached Medicine News:Health News:Senetek PLC Announces Launch of New Website 2Health News:Massive American Red Cross Tornado Relief Effort Spans Five States 2Health News:Treating acne: 2 different acid peels are both effective, study finds 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 3Health News:Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 3
... Trappers are ideal for use with custom ... Finger Trappers' non-slip foam lining replaces fingernail ... in traction. These are truly the "No ... packages of 5 and boxes of 25. ...
One splint does it all....
... heavy duty, controlled stretch knee brace provides ... or for those individuals with a history ... metal bars provide excellent side-to-side support, yet ... The elastic sleeve supports the entire knee ...
... is a heavy duty, controlled stretch knee ... pain while allowing full range of motion. ... bend with the knee, and help to ... wearing comfort. This is an excellent ...
Medicine Products: